TScan Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding for Q1 2022

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
TScan Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate for Q1 2022.
  • TScan Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending March 4, 2022 was 24M shares.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Period Value YoY Chg Change % Date Report Filed
Q1 2022 24M Mar 4, 2022 10-K 2022-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.